ENTX
Price
$2.08
Change
-$0.15 (-6.73%)
Updated
Apr 30, 12:41 PM (EDT)
Capitalization
103.56M
9 days until earnings call
ORKA
Price
$10.22
Change
-$0.22 (-2.11%)
Updated
Apr 30, 01:00 PM (EDT)
Capitalization
384.89M
Ad is loading...

ENTX vs ORKA

Header iconENTX vs ORKA Comparison
Open Charts ENTX vs ORKABanner chart's image
Entera Bio
Price$2.08
Change-$0.15 (-6.73%)
Volume$44.36K
Capitalization103.56M
Oruka Therapeutics
Price$10.22
Change-$0.22 (-2.11%)
Volume$100
Capitalization384.89M
ENTX vs ORKA Comparison Chart
Loading...
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTX vs. ORKA commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a Buy and ORKA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (ENTX: $2.23 vs. ORKA: $10.45)
Brand notoriety: ENTX and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 55% vs. ORKA: 57%
Market capitalization -- ENTX: $103.56M vs. ORKA: $384.89M
ENTX [@Biotechnology] is valued at $103.56M. ORKA’s [@Biotechnology] market capitalization is $384.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green whileORKA’s FA Score has 1 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • ORKA’s FA Score: 1 green, 4 red.
According to our system of comparison, ORKA is a better buy in the long-term than ENTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 5 TA indicator(s) are bullish while ORKA’s TA Score has 5 bullish TA indicator(s).

  • ENTX’s TA Score: 5 bullish, 6 bearish.
  • ORKA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ORKA is a better buy in the short-term than ENTX.

Price Growth

ENTX (@Biotechnology) experienced а +13.78% price change this week, while ORKA (@Biotechnology) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.55%. For the same industry, the average monthly price growth was +2.15%, and the average quarterly price growth was -10.01%.

Reported Earning Dates

ENTX is expected to report earnings on Aug 08, 2025.

ORKA is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+1.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORKA($385M) has a higher market cap than ENTX($104M). ENTX YTD gains are higher at: 5.189 vs. ORKA (-46.106). ORKA has more cash in the bank: 411M vs. ENTX (6.92M). ENTX has less debt than ORKA: ENTX (309K) vs ORKA (988K).
ENTXORKAENTX / ORKA
Capitalization104M385M27%
EBITDA-9.16MN/A-
Gain YTD5.189-46.106-11%
P/E RatioN/AN/A-
Revenue99KN/A-
Total Cash6.92M411M2%
Total Debt309K988K31%
FUNDAMENTALS RATINGS
ENTX vs ORKA: Fundamental Ratings
ENTX
ORKA
OUTLOOK RATING
1..100
1915
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3951
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORKA's Valuation (5) in the null industry is significantly better than the same rating for ENTX (80) in the Pharmaceuticals Major industry. This means that ORKA’s stock grew significantly faster than ENTX’s over the last 12 months.

ENTX's Profit vs Risk Rating (93) in the Pharmaceuticals Major industry is in the same range as ORKA (100) in the null industry. This means that ENTX’s stock grew similarly to ORKA’s over the last 12 months.

ENTX's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as ORKA (100) in the null industry. This means that ENTX’s stock grew similarly to ORKA’s over the last 12 months.

ENTX's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as ORKA (51) in the null industry. This means that ENTX’s stock grew similarly to ORKA’s over the last 12 months.

ENTX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as ORKA (100) in the null industry. This means that ENTX’s stock grew similarly to ORKA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTXORKA
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AOIFF1.320.02
+1.54%
Africa Oil Corp.
CAJPY31.020.15
+0.49%
Canon, Inc.
ZLNDY19.29-0.17
-0.88%
ZALANDO SE
MBGAF61.71-0.64
-1.03%
Mercedes Benz Group AG
AICOF0.09N/A
-3.61%
Generative AI Solutions Corp.

ENTX and

Correlation & Price change

A.I.dvisor tells us that ENTX and JSPR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTX and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
-2.19%
JSPR - ENTX
32%
Poorly correlated
+7.29%
OPORF - ENTX
31%
Poorly correlated
N/A
PLX - ENTX
30%
Poorly correlated
+3.86%
ORKA - ENTX
28%
Poorly correlated
+1.65%
KOD - ENTX
28%
Poorly correlated
-1.19%
More

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with PCVX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
+1.65%
PCVX - ORKA
44%
Loosely correlated
+5.68%
RLFTF - ORKA
31%
Poorly correlated
+5.56%
ENTX - ORKA
28%
Poorly correlated
-2.19%
RLFTY - ORKA
24%
Poorly correlated
-7.69%
CMMB - ORKA
22%
Poorly correlated
-4.48%
More